Literature DB >> 11469885

Mechanisms of taxotere-related drug resistance in pancreatic carcinoma.

B Liu1, E D Staren, T Iwamura, H E Appert, J M Howard.   

Abstract

BACKGROUND: Pancreatic adenocarcinoma (PAC) is generally refractory to most chemotherapeutic agents, including docetaxel (Taxotere; TXT). Specific mechanisms for TXT-related drug resistance in PAC have not been defined. The hypothesis of this study was that PAC resistance to TXT is primarily related to P-glycoprotein (P-gp), the expression product of multiple drug resistance (MDR)-1, as opposed to lung resistance protein (LRP) or multidrug resistance protein (MRP).
MATERIALS AND METHODS: The sensitivity of the PAC cell line SUIT-2 and its sublines to TXT, doxorubicin (DOX) and 5-fluorouracil (5-FU) was evaluated with a 3-[4,5-dimethylthiazol-2-yl]-2,5-diphenyltetrazolium bromide assay. MDR1 (P-gp), MRP, LRP, and beta-tubulin isotype gene expressions were detected at the messenger RNA level by reverse transcription-polymerase chain reaction (RT-PCR). Verapamil and indomethacin (IMC) were used to test the functionality of P-gp and MRP, respectively.
RESULTS: The SUIT-2 subline S-020 and the TXT-selected SUIT-2 cell line S2/TXT were significantly resistant to TXT. Both showed cross-resistance to DOX but no resistance to 5-FU. RT-PCR demonstrated strong expression of P-gp in S-020 and S2/TXT and weaker or no expression in other cells lines. MRP and LRP expression was found in most of these cell lines but had no relationship to the TXT resistance. TXT resistance in S2-020 and S2/TXT could be reversed by verapamil but not by IMC. Levels of beta-tubulin isotype II and III were increased in S2/TXT compared with S-020 and SUIT-2.
CONCLUSIONS: Intrinsic and acquired TXT resistance is primarily mediated by P-gp, but not by MRP or LRP, and is markedly reversed by the P-gp modulator verapamil. Hence future related studies should focus on the use of agents that block the transporter action of P-gp. Copyright 2001 Academic Press.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11469885     DOI: 10.1006/jsre.2001.6126

Source DB:  PubMed          Journal:  J Surg Res        ISSN: 0022-4804            Impact factor:   2.192


  17 in total

Review 1.  Microtubule targeting agents: from biophysics to proteomics.

Authors:  D Calligaris; P Verdier-Pinard; F Devred; C Villard; D Braguer; Daniel Lafitte
Journal:  Cell Mol Life Sci       Date:  2010-01-28       Impact factor: 9.261

Review 2.  Metastatic gastric cancer treatment: Second line and beyond.

Authors:  Marwan Ghosn; Samer Tabchi; Hampig Raphael Kourie; Mustapha Tehfe
Journal:  World J Gastroenterol       Date:  2016-03-21       Impact factor: 5.742

3.  Mechanism of 5-fluorouracil required resistance in human hepatocellular carcinoma cell line Bel(7402).

Authors:  Jing Jin; Min Huang; Huai-Ling Wei; Geng-Tao Liu
Journal:  World J Gastroenterol       Date:  2002-12       Impact factor: 5.742

4.  Second generation benzofuranone ring substituted noscapine analogs: synthesis and biological evaluation.

Authors:  Ram Chandra Mishra; Prasanthi Karna; Sushma Reddy Gundala; Vaishali Pannu; Richard A Stanton; Kamlesh Kumar Gupta; M Hope Robinson; Manu Lopus; Leslie Wilson; Maged Henary; Ritu Aneja
Journal:  Biochem Pharmacol       Date:  2011-04-08       Impact factor: 5.858

Review 5.  [Biomarkers - the way towards individualized chemotherapy in non-small cell lung cancer (NSCLC)].

Authors:  Sabine Danzinger; Martin Filipits
Journal:  Wien Med Wochenschr       Date:  2007

6.  Comparing the relationship of Taxol-based chemotherapy response with P-glycoprotein and lung resistance-related protein expression in non-small cell lung cancer.

Authors:  J F Chiou; J A Liang; W H Hsu; J J Wang; S T Ho; A Kao
Journal:  Lung       Date:  2003       Impact factor: 2.584

7.  Role of anti-stromal polypharmacy in increasing survival after pancreaticoduodenectomy for pancreatic ductal adenocarcinoma.

Authors:  Samuel J Tingle; John A Moir; Steven A White
Journal:  World J Gastrointest Pathophysiol       Date:  2015-11-15

8.  Increased mitochondrial DNA induces acquired docetaxel resistance in head and neck cancer cells.

Authors:  T Mizumachi; S Suzuki; A Naito; J Carcel-Trullols; T T Evans; P M Spring; N Oridate; Y Furuta; S Fukuda; M Higuchi
Journal:  Oncogene       Date:  2007-07-16       Impact factor: 9.867

9.  Using technetium-99m tetrofosmin chest imaging to predict taxol-based chemotherapy response in non-small cell lung cancer but not related to lung resistance protein expression.

Authors:  C-M Shih; Y-C Shiau; J-J Wang; S-T Ho; A Kao
Journal:  Lung       Date:  2003       Impact factor: 2.584

10.  The roles of beta-tubulin mutations and isotype expression in acquired drug resistance.

Authors:  J Torin Huzil; Ke Chen; Lukasz Kurgan; Jack A Tuszynski
Journal:  Cancer Inform       Date:  2007-04-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.